Newsletter Subject

Two Doctors Charged in Connection With Matthew Perry's Death

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Aug 17, 2024 11:15 AM

Email Preheader Text

Weekly Review Saturday, August 17, 2024 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT CM

[MEDPAGE TODAY]( Weekly Review Saturday, August 17, 2024 [Two Doctors Charged in Connection With Matthew Perry's Death]( [Well-Being Declines Before Mild Cognitive Impairment]( [Medicare Unveils First 10 Negotiated Drug Prices]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Elevating Treatment Selection and Sequencing in Multiple Myeloma: Personalized Decisions Through Lines of Therapy]( [Death Is Inevitable. It's Time We Learned to Talk About It.]( [He Hadn't Had a Drop of Alcohol in Nearly a Year -- But the Test Said Otherwise]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [Methotrexate for Knee Osteoarthritis; Evaluating Squamous Cell Cancers]( CME SPOTLIGHT [Exploring HER2 Targeting: Transforming Treatment for Metastatic and Locally Advanced HER2+ Cancers]( [Where Harris and Trump Stand on Top Issues in Healthcare]( [Doc Sentenced to 24 Years; $17M Jury Award; Ectopic Pregnancy Lawsuits]( [ABIM Revokes Two Doctors' Certifications Over COVID Comments]( CME SPOTLIGHT [Optimizing Infusion Therapies to Advance Care in Metastatic HR+/HER2- and Triple-Negative Breast Cancer]( [Dementia Risk Dropped With Anti-Inflammatory Diet for Certain Patients]( [Melatonin and Alzheimer's; Napping-Parkinson's Link; An Unusual ARIA Case]( [FDA Warns Against Smelling Salts]( CME SPOTLIGHT [Navigating Endocrine Resistance: Latest Strategies in HR+/HER2- Breast Cancer Care]( [CDC Alerts on Dramatic Rise in Human Parvovirus B19]( [PBMs Are Stacking the Deck Against Patients and Independent Physician Practices]( [SGLT2 Hesitance; Furosemide's Indication Grows; Legal Fight Over Entresto Generic]( CME SPOTLIGHT [Optimizing Use of PARP Inhibitors in Early-Stage and Metastatic Breast Cancer Patients With DNA Damage Repair Pathway Mutations]( [Blood Test for Colon Cancer: Panacea or Hype?]( ['Not Game-Over for COVID': What We Heard This Week]( [MDMA Papers Retracted; School Bans Black Clothing; TikTok and Disordered Eating]( CME SPOTLIGHT [The Evolving Treatment Landscape for Triple-Negative Breast Cancer: New Targeted, Immuno-Oncology, and Emerging Combination Approaches]( [One in Four Brain Injury Patients Who Appear Unresponsive Respond Covertly]( [Did COVID Vax Mandates for Health Workers Increase Uptake?]( [Preschoolers' Tablet Time Linked to Increase in Anger Outbursts]( CME SPOTLIGHT [Advancing the Integration of Biomarker Testing to Inform Treatment Selection in Advanced G/GEJ Cancers]( [What Medicare Advantage Changes Would a Trump or Harris Administration Make?]( ['Scared to Death': Nurses, Residents Confront Violence in Dementia Care Facilities]( [Shingles Tied to Long-Term Cognitive Changes]( CME SPOTLIGHT [Applying the Latest Clinical Evidence to Treatment Plans for Pediatric Patients With Hodgkin Lymphoma]( [More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer]( [What to Know About the Doctors Charged in Matthew Perry's Death]( ['Inside Out 2': How New Emotions Mirror Medical Student Struggles]( [Social Media Bans Could Deny Teenagers Mental Health Help]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2024-08-17&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.